SEC Form 4 · accession 0001127602-19-008794
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Birgit Girshick
Officer — Corporate Executive VP
Period of report
Feb 26, 2019
Accepted (ET)
Feb 28, 2019 · 9:33 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 26, 2019 | F | 152 | $145.31 | D | 24,170 | D | |
| Common Stock | Feb 27, 2019 | F | 125 | $140.71 | D | 24,045 | D |
Table II — derivative securities
No Table II lines on this filing.